Paper498147
Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.
Litterst CL and 2 others. Cancer Treat Rep, 1979. Cited by 119 papers, by iCite.
Cite this record
ConductScience Library. Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals. Papers, record 498147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/498147
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cisplatin | Major topic |
| Animals | |
| Dogfish | |
| Dogs | |
| Female | |
| Half-Life | |
| Injections, Intravenous | |
| Male | |
| Mice | |
| Rats | |
| Tissue Distribution |
Source PubMed
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26244343 | Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometric (LC/ESI-MS/MS) Study for the Identification and Characterization of In Vivo Metabolites of Cisplatin in Rat Kidney Cancer Tissues: Online Hydrogen/Deuterium (H/D) Exchange Study. | PLoS One | 2015 | https://conductscience.org/library/papers/26244343 | PubMed |
| 24966482 | Polybutylcyanoacrylate nanoparticles and drugs of the platinum family: last status. | Indian J Clin Biochem | 2014 | https://conductscience.org/library/papers/24966482 | PubMed |
| 21941418 | Prediction of nephrotoxicity induced by cisplatin combination chemotherapy in gastric cancer patients. | World J Gastroenterol | 2011 | https://conductscience.org/library/papers/21941418 | PubMed |
| 19625999 | Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity. | Clin Pharmacol Ther | 2009 | https://conductscience.org/library/papers/19625999 | PubMed |
| 19419663 | Pica as an adaptive response: Kaolin consumption helps rats recover from chemotherapy-induced illness. | Physiol Behav | 2009 | https://conductscience.org/library/papers/19419663 | PubMed |
| 19362521 | Brain Fos expression induced by the chemotherapy agent cisplatin in the rat is partially dependent on an intact abdominal vagus. | Auton Neurosci | 2009 | https://conductscience.org/library/papers/19362521 | PubMed |
| 15185124 | WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects. | J Assoc Res Otolaryngol | 2004 | https://conductscience.org/library/papers/15185124 | PubMed |
| 9266451 | Phase II trial of cisplatinum and etoposide in brain metastases of solid tumors. | J Neurooncol | 1997 | https://conductscience.org/library/papers/9266451 | PubMed |
| 8033299 | Effects of intralesional injection of cisplatin dissolved in urografin and lipiodol on Ehrlich ascites tumor and normal tissues of CD-1 mice. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8033299 | PubMed |
| 7595753 | Permeability change and brain tissue damage after intracarotid administration of cisplatin studied by double-tracer autoradiography in rats. | J Neurooncol | 1995 | https://conductscience.org/library/papers/7595753 | PubMed |
| 7497593 | Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7497593 | PubMed |
| 7201357 | Alterations in hepatic and renal levels of glutathione and activities of glutathione S-transferase from rats treated with cis-dichlorodiammineplatinum-II. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/7201357 | PubMed |
| 7200368 | Renal and haemopoietic proliferative defects as a delayed consequence of cis-platin, adriamycin and daunomycin treatments. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7200368 | PubMed |
| 7199350 | Proliferative defects in renal and intestinal epithelium after cis-dichlorodiammine platinum (II). | Br J Cancer | 1982 | https://conductscience.org/library/papers/7199350 | PubMed |
| 6891626 | Human tissue distribution of platinum after cis-diamminedichloroplatinum. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6891626 | PubMed |
| 6788166 | Haemolytic anaemia after cisplatin treatment. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6788166 | PubMed |
| 6761344 | Phase II clinical trial of cis dichlorodiammine platinum (Cis DDP) in metastatic brain tumors. | J Cancer Res Clin Oncol | 1982 | https://conductscience.org/library/papers/6761344 | PubMed |
| 6241789 | Cisplatinum: a review, with special reference to cellular and molecular interactions. | Agents Actions | 1984 | https://conductscience.org/library/papers/6241789 | PubMed |
| 6189661 | Clinical pharmacokinetics of commonly used anticancer drugs. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6189661 | PubMed |
| 4053273 | Platinum concentration in human tumors of head and neck, uterine cervix, and breast following treatment with cisplatin. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/4053273 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/498147
GET https://conductscience.org/api/papers/v1/498147/cited_by?page=2